Sands Capital wraps up sophomore life sciences fund at $560m

Sands Capital has closed its second life sciences fund at $560 million.

16 August 2021•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Fundraising Fundraising Briefs